share_log

Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Market Cap Dropped CN¥380m Last Week; Private Companies Bore the Brunt

上海浩源化学科技股份有限公司(SHSE: 688131)の時価総額は先週CN¥380m減少しました。民間企業が最も被害を受けました。

Simply Wall St ·  05/27 18:29

Key Insights

  • The considerable ownership by private companies in Shanghai Haoyuan Chemexpress indicates that they collectively have a greater say in management and business strategy
  • 51% of the business is held by the top 5 shareholders
  • Institutional ownership in Shanghai Haoyuan Chemexpress is 23%

Every investor in Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are private companies with 40% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

And last week, private companies endured the biggest losses as the stock fell by 7.9%.

Let's take a closer look to see what the different types of shareholders can tell us about Shanghai Haoyuan Chemexpress.

ownership-breakdown
SHSE:688131 Ownership Breakdown May 27th 2024

What Does The Institutional Ownership Tell Us About Shanghai Haoyuan Chemexpress?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

As you can see, institutional investors have a fair amount of stake in Shanghai Haoyuan Chemexpress. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Shanghai Haoyuan Chemexpress' historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
SHSE:688131 Earnings and Revenue Growth May 27th 2024

Shanghai Haoyuan Chemexpress is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is Shanghai Anxu Information Technology Co., Ltd. with 32% of shares outstanding. In comparison, the second and third largest shareholders hold about 7.1% and 4.0% of the stock.

On looking further, we found that 51% of the shares are owned by the top 5 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Shanghai Haoyuan Chemexpress

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

Our information suggests that Shanghai Haoyuan Chemexpress Co., Ltd. insiders own under 1% of the company. However, it's possible that insiders might have an indirect interest through a more complex structure. It seems the board members have no more than CN¥7.0m worth of shares in the CN¥4.4b company. We generally like to see a board more invested. However it might be worth checking if those insiders have been buying.

General Public Ownership

With a 26% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Shanghai Haoyuan Chemexpress. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Equity Ownership

Private equity firms hold a 7.1% stake in Shanghai Haoyuan Chemexpress. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

Private Company Ownership

It seems that Private Companies own 40%, of the Shanghai Haoyuan Chemexpress stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Shanghai Haoyuan Chemexpress better, we need to consider many other factors. For example, we've discovered 1 warning sign for Shanghai Haoyuan Chemexpress that you should be aware of before investing here.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする